Efficacy, safety, and tolerability of valsartan/hydrochlorothiazide in Asian patients with essential hypertension

被引:0
|
作者
Wen-Ter Lai
Jeong-Euy Park
Neelesh Dongre
Jackson Wang
机构
[1] Kaohsiung Medical University Hospital,Division of Cardiology, Department of Internal Medicine
[2] Samsung Medical Center,Cardiology Division
[3] Novartis Pharma AG,Scientific Operations Department, Asia
[4] Novartis (Taiwan) Co.,Pacific, Middle East & African Countries
[5] Ltd.,Scientific Operations Department
来源
Advances in Therapy | 2011年 / 28卷
关键词
Asian; combination therapy; efficacy; hypertension; tolerability; valsartan/hydrochlorothiazide single pill;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:427 / 438
页数:11
相关论文
共 50 条
  • [21] Efficacy and tolerability of the combination valsartan/hydrochlorothiazide compared with amlodipine in a mild-to-moderately hypertensive Brazilian population
    Franco, RJS
    Goldflus, S
    Mcquitty, M
    Oigman, W
    BLOOD PRESSURE, 2003, 12 : 41 - 47
  • [22] Efficacy and tolerability of once-daily 160 mg valsartan in Chinese patients with mild to moderate hypertension
    Sun, Ningling
    Feng, Yingqing
    Gao, Pingjin
    Chen, Xiaoping
    Qi, Litong
    Zhang, Shuyang
    Dong, Yugang
    Yang, Xinchun
    Li, Xinli
    Chen, Yundai
    Liu, Lingli
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2017, 13 (03) : 1109 - 1116
  • [23] A DOUBLE-BLIND COMPARISON OF THE EFFICACY AND SAFETY OF LACIDIPINE AND HYDROCHLOROTHIAZIDE IN ESSENTIAL-HYPERTENSION
    CHIARIELLO, M
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1991, 17 : S35 - S37
  • [24] A Review of the Efficacy and Tolerability of Combination Amlodipine/Valsartan in Non-White Patients with Hypertension
    Ferdinand, Keith C.
    Nasser, Samar A.
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2013, 13 (05) : 301 - 313
  • [25] Efficacy and safety of sacubitril/valsartan in patients with essential hypertension uncontrolled by olmesartan: A randomized, double-blind, 8-week study
    Cheung, Deanna G.
    Aizenberg, Diego
    Gorbunov, Vladimir
    Hafeez, Kudsia
    Chen, Chien-Wei
    Zhang, Jack
    JOURNAL OF CLINICAL HYPERTENSION, 2018, 20 (01) : 150 - 158
  • [26] Efficacy and safety of a single-pill combination of amlodipine/valsartan in Asian hypertensive patients inadequately controlled with amlodipine monotherapy
    Ke, YuanNan
    Zhu, DingLiang
    Hong, HuaShan
    Zhu, JunRen
    Wang, RuoNan
    Cardenas, Pamela
    Zhang, Ying
    CURRENT MEDICAL RESEARCH AND OPINION, 2010, 26 (07) : 1705 - 1713
  • [27] Effectiveness of initiating treatment with valsartan/hydrochlorothiazide in patients with stage-1 or stage-2 hypertension
    Zappe, D. H.
    Palmer, B. F.
    Calhoun, D. A.
    Purkayastha, D.
    Samuel, R.
    Jamerson, K. A.
    JOURNAL OF HUMAN HYPERTENSION, 2010, 24 (07) : 483 - 491
  • [28] Amlodipine/valsartan/hydrochlorothiazide triple combination therapy in moderate/severe hypertension: Secondary analyses evaluating efficacy and safety
    David A. Calhoun
    Nora A. Crikelair
    Joseph Yen
    Robert D. Glazer
    Advances in Therapy, 2009, 26 : 1012 - 1023
  • [29] Effects of force-titrated valsartan/hydrochlorothiazide versus amlodipine/hydrochlorothiazide on ambulatory blood pressure in patients with stage 2 hypertension: the EVALUATE study
    Lacourciere, Yves
    Wright, Jackson T., Jr.
    Samuel, Rita
    Zappe, Dion
    Purkayastha, Das
    Black, Henry R.
    BLOOD PRESSURE MONITORING, 2009, 14 (03) : 112 - 120
  • [30] Long-term safety, tolerability and efficacy of aliskiren in combination with valsartan in patients with hypertension: a 6-month interim analysis
    Chrysant, Steven G.
    Murray, Alexander V.
    Hoppe, Uta C.
    Dattani, Dan
    Patel, Sarnir
    Hsu, Huang
    Zhang, Jack
    CURRENT MEDICAL RESEARCH AND OPINION, 2008, 24 (04) : 1039 - 1047